-
Is Ventas's Astounding 320% 10-Year Shareholder Return Plausible Going Forward? Q3 Earnings & Future Focus
Monday, October 27, 2014 - 9:25am | 1020Read More...During the past decade or so, investors in this leading health care REIT have been rewarded with outsized gains. What do Q3 earnings and future plans tell investors moving forward? Past Performance The Ventas, Inc. (NYSE: VTR) website displays a calculated 10-year total shareholder return of...
-
Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension Improving
Thursday, August 14, 2014 - 4:37pm | 2822Read More...U.S. stocks rose to close the day with moderate gains despite a larger than expected increase in jobless claims. “The end of 2015 Q1 is still my preferred liftoff date,” St. Louis Fed President Jim Bullard told The Wall Street Journal. The end of the first quarter is ahead of the...
-
Markets Higher In Another Quiet Session Ahead Of Expiration Of Ceasefire Between Israel And Hamas
Wednesday, August 13, 2014 - 4:43pm | 2982Read More...U.S. stocks rose for the third time in four days bringing the Dow back into positive territory for the year. Investors appeared to brush up poor retail sales from Macy's while focusing on business inventories that rose in June. On the international front, Ukraine said it would not allow...
-
An Obamacare Boost For Health Care REITs?
Thursday, March 20, 2014 - 7:15am | 853Read More...What does Obamacare care mean for health care real estate investment trusts (REITS) such as HCP (NYSE: HCP), Health Care REIT (NYSE: HCN), Healthcare Trust of America (NYSE: HTA) and Ventas (NYSE: VTR)? Scott Peters, chief executive of Healthcare Trust of America, told MarketWatch this week that...
-
Earnings Expectations For The Week Of February 17: Coca-Cola, Hewlett-Packard, Wal-Mart & More
Tuesday, February 18, 2014 - 7:36am | 914Read More...The earnings season is winding down, but on the docket this week are Coca-Cola (NYSE: KO), Groupon (NASDAQ: GRPN), Hewlett-Packard (NYSE: HPQ), MGM Resorts (NYSE: MGM), Tesla Motors (NASDAQ: TSLA) and others. Later in the week, the parade of quarterly reports from big retailers kicks off with...
-
Three More Defensive Stock Picks for 2013 (LLY, PFE, VTR)
Monday, December 10, 2012 - 4:12pm | 644Read More...Bank of America Merrill Lynch offered some defensive stock picks for 2013 in a research report. Two drug makers and an REIT focused on health care facilities made the list. They were Eli Lilly (NYSE: LLY), Pfizer (NYSE: PFE) and Ventas (NYSE: VTR). Here is a quick look at how these three picks...
-
Morgan Keegan Reiterates Outperform and PT of $59.50 on Health Care REIT
Tuesday, May 24, 2011 - 8:15am | 102Read More...Morgan Keegan reiterated its outperform rating on Health Care REIT (NYSE: HCN) after the company decided to purchase $80 million worth of real estates. In a research report published today, Morgan Keegan states, "This will increase Health Care REIT's LTAC holdings to 22 hospitals with an...
-
Morgan Keegan Raises HCN Target From $59 To $59.50
Wednesday, May 4, 2011 - 7:15am | 31Read More...Morgan Keegan is raising its PT on shares of Health Care REIT Inc. (NYSE: HCN) from $59 to $59.50. Health Care REIT closed Tuesday at $53.50.
-
Morgan Keegan Preview HCN 1Q
Monday, April 25, 2011 - 8:32am | 106Read More...Health Care REIT Inc. (NYSE: HCN), which will report earnings on Tuesday, May 3, is getting a first quarter preview from Morgan Keegan. “Our FFO/share estimate of $0.76 is $0.02 above the First Call consensus and $0.01 above the prior year period,” Morgan Keegan writes. “Our FAD/share estimate of...
-
J.P. Morgan Adjusts HCN Estimates
Thursday, April 7, 2011 - 8:06am | 117Read More...J.P. Morgan has adjusted its normalized 2011 and 2012 FFO estimates on Health Care REIT Inc. (NYSE: HCN) to $3.39 and $3.80/share from $3.37 and $3.81/share, respectively. “These estimates exclude the impact of one-time items and acquisition costs,” J.P. Morgan writes. “Our revised estimates...
-
Morgan Keegan Maintains Outperform on Health Care REIT (HCN)
Tuesday, April 5, 2011 - 7:47am | 86Read More...Morgan Keegan is out with its report today on Health Care REIT (NYSE: HCN), maintaining Outperform. In a note to clients, Morgan Keegan writes, "We believe that Health Care REIT can sustain 4%-5% FFO growth long-term through internal growth, accretive acquisitions, and facility development. Our...
-
Morgan Keegan Analyzes Publicly Traded Healthcare REITs (HCP, HCN, VTR, NHP)
Wednesday, March 16, 2011 - 7:20am | 217Read More...In a report released this morning, Morgan Keegan provides an analysis of publicly traded healthcare REITs with respect to FFO/FAD, investment composition, and asset coverage ratios. “Since our last report, we have seen four noteworthy large deals: HCP, Inc.'s (NYSE: HCP) $6.1 billion acquisition of...
-
Jefferies Raises PT On Health Care REIT To $60
Tuesday, March 1, 2011 - 8:12am | 28Read More...Jefferies & Company has raised the price target on Health Care REIT (NYSE: HCN) from $55 to $60 and maintains its Buy raitng.
-
JP Morgan's PT Changes On REITs
Friday, January 14, 2011 - 10:18am | 343Read More...JP Morgan has changed the price targets on the following REITs: Acadia Realty Trust (NYSE: AKR) 18.09 Neutral $17.00 to $18.00 AMB Property Corporation (NYSE: AMB) $32.46 Neutral $30.00 to $26.00 Boston Properties (NYSE: BXP) $86.46 Overweight $110.00 to $91.00 CB Richard Ellis Group, Inc. (NYSE:...
-
Jefferies Adjusts Health Care REIT Estimates; Lowers PT To $54
Wednesday, December 1, 2010 - 8:39am | 92Read More...Jefferies & Company is revising its Health Care REIT (NYSE: HCN) 2010, 2011, and 2012 FFO/share estimates to $3.11, $3.20, and $3.48, from $3.11, $3.32, and $3.55, respectively. “Our adjustments reflect: 1) 3Q10 results; 2) dilution from the recent senior unsecured note issuance ($450M @ 4.95...
